Navigation Links
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
Date:6/14/2008

o the same period of time prior to treatment. (5-7)

In the presentation by Dr. Hill, data on 164 patients with PNH were derived from two Phase 3 studies of Soliris as a treatment for PNH: TRIUMPH, a six-month, double-blind, placebo-controlled study, and SHEPHERD, a 12-month, open-label study. Data on anemic cancer patients were obtained from a published report.(8) Patient-reported fatigue in both groups of patients was determined utilizing the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale. Anemia was measured by levels of hemoglobin, and hemolysis was measured by levels of lactate dehydrogenase (LDH). Key findings included the following:

* While intravascular hemolysis reduction (decreased LDH) and anemia

improvement (increased hemoglobin) were both significantly associated

with fatigue improvement (odds ratio 1.11, P<0.001 and 1.29, P=0.005,

respectively), hemolysis reduction was predictive of an improvement in

fatigue independent of an improvement in anemia in patients with PNH

(1.07, P=0.028).

* The improvement in fatigue was greater (P=0.002) in Soliris-treated PNH

patients compared to EPO-treated anemic cancer patients.

* When the magnitude of clinical impact was analyzed by using standard

descriptors for the Effect Size (ES) measurement of fatigue in both

groups, (9)

* PNH patients treated with Soliris experienced a large improvement in

fatigue, (ES: +1.0) when the hemoglobin level increased as compared to

anemic cancer patients treated with EPO who experienced only a small

improvement in fatigue (ES: +0.48).

* Similarly, PNH patients treated with Soliris experienced a moderate

improvement in fatigue (ES:+0.72) when hemoglobin levels did not

improve compared to EPO-treated anemic cancer patients for whom

fatigue scores did not change meaningfully (ES:+0.15) when hem
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
2. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
4. Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
5. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
8. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
9. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
10. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
11. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)... (NYSE: RMD ) today announced results for its ... $423.0 million, a 10 percent increase compared to the quarter ... constant currency basis). Net income was $91.2 million, an increase ... 2013. Diluted earnings per share for the quarter were $0.64, ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... China, Feb. 8, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical ... a pharmaceutical company that develops, manufactures and markets ... and other pharmaceuticals, today announced that the senior ... its fiscal year 2011 second quarter financial results ...
... Feb. 8, 2011 Beckman Coulter, Inc. (NYSE: ... of products that simplify, automate and innovate complex biomedical ... a quarterly dividend payout of nineteen cents ($0.19) per ... 2011 to all stockholders of record on March 3, ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2011 Second Quarter Earnings Conference Call on Tuesday, February 15, 2011 at 8:30 a.m. E.T. 2Beckman Coulter Declares Quarterly Dividend Payout of $0.19 Per Share 2Beckman Coulter Declares Quarterly Dividend Payout of $0.19 Per Share 3
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Autocarinsurancebest.com has released ... purchasing a commercial auto insurance policy . , Auto ... their vehicles. It is no longer necessary to call an ... are now available online on a single website: http://autocarinsurancebest.com/ ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the basic ... , Purchasing an accidental death and dismemberment rider for a ... rider provides benefits if the insured dies in an accident. ... of life insurance. , AD&D is not expensive and ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... has added many trendy Champagne wedding dresses to ... the past three years. Today, the business announces a special ... the sales manager of the company, this is on the ... point can be reflected on the discounted wedding dresses from ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... Clinic in West Palm BeachMERRIMACK, N.H., Jan. 28 ... body shaping, announced a new partnership with Anushka and ... in West Palm Beach. The 12,000 square foot ... the Palm Beach area to offer the SmoothShapes(R) system ...
... 28 With 27 years of experience in ... Kimberlin-Murphy reveals the behind-the-scenes knowledge she,s cultivated in ... Medical Collector, The Patient,s Guide to Avoiding Bankruptcy" ... the American medical patient and medical community with ...
... are breaking new ground in research"), you will find ... on the opportunities and risks of the whole-body tomographs ... Delbrck Center) in Berlin. , Snap-shots of a diseased ... 7-tesla magnetic resonance tomograph promises scientists novel possibilities. The ...
... PEAK Surgical, Inc., a medical,device company that ... on a,proprietary technology, announced today that it has ... System for use in general surgery. The PEAK,Surgery ... PlasmaBlade(TM),family of disposable, low-temperature surgical cutting and coagulation,devices. ...
... + Fields Dermatologists, the,clinical skincare brand developed by Stanford ... pleased to,announce the recent addition of Robert "Bob" M. Henry ... Fields is the most exciting opportunity in direct selling today.,Following ... future to,be bright," says Henry. , ...
... Uninformed about Cavity-Causing Bacteria and Teeth-Friendly SnacksCHICAGO, Jan. ... the American Academy of Pediatric Dentistry (AAPD), the ... and caregivers are unaware that routine practices, such ... increase children,s risk of developing cavities. To view ...
Cached Medicine News:Health News:Anushka * Cellulite Clinic * Cosmedical Centre Introduces Next Generation Cellulite Treatment 2Health News:Anushka * Cellulite Clinic * Cosmedical Centre Introduces Next Generation Cellulite Treatment 3Health News:'Secrets Revealed By A Medical Collector, The Patient's Guide to Avoiding Bankruptcy' 2Health News:'Secrets Revealed By A Medical Collector, The Patient's Guide to Avoiding Bankruptcy' 3Health News:For sharper pictures of the body's interior 2Health News:PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery 2Health News:PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery 3Health News:Direct Selling Luminary, Robert M. Henry, Partners With Rodan + Fields(R) Dermatologists as Strategic Business Advisor 2Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 2Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 3Health News:Video: Most Parents and Caregivers Unaware Their Best Intentions May Be Fostering Tooth Decay in Children 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: